Modafinil / Armodafinil

Modafinil and armodafinil are wakefulness-promoting drugs developed for narcolepsy, shift work sleep disorder, and residual sleepiness in treated obstructive sleep apnoea. They work mainly by raising dopamine, with secondary lifts in noradrenaline, histamine, and orexin, the same neurotransmitters that drive normal waking. Most people use them off-label as a long-acting cognitive lever for the days that genuinely demand it, a sleep-deprived 12-hour push, an exam, a flight schedule that wrecks circadian rhythm, a deadline you can't move. They give you 8-12 hours of clean wakefulness without the body buzz, crash, or appetite collapse that amphetamines come with.

The practical effect is that you stay sharp for longer, your focus holds across tasks that would normally fragment, and the urge to nap or zone out largely disappears. They are not a productivity miracle on a normal day. If you're well-rested and the task is interesting, you'll mostly notice you can't fall asleep. The bigger effect shows up on the difficult days: longer attention span, better working memory under fatigue, and steadier performance on long, complex tasks. The trade-off is they're prescription drugs with real side effects (headache, anxiety, insomnia, raised blood pressure, rare but serious skin reactions), they interact with hormonal contraception, and they can build tolerance with daily use.

Armodafinil is the R-enantiomer of modafinil, the half that lasts longer in the body. Practically, 150 mg of armodafinil produces similar peak effects to 200 mg of modafinil but holds plasma levels higher into the late afternoon, which is why some people prefer it for full-day coverage and others find it harder to sleep that night. Same mechanism, slightly different curve.

Deep-dive

The mechanism is still not fully nailed down, which is unusual for a drug this well-studied. The clearest finding is that modafinil binds to and inhibits the dopamine transporter (DAT), raising extracellular dopamine in the striatum and prefrontal cortex. Dopamine transporter knockout mice don't respond to modafinil, and humans homozygous for a slow-degrading COMT variant (already high baseline dopamine) show blunted cognitive enhancement compared to fast-degrading variants. Dopamine matters.

But DAT inhibition alone doesn't explain the wakefulness profile, because cocaine and amphetamine hit the same target far more potently and produce a very different drug. Modafinil also activates orexin and histamine neurons in the hypothalamus, the same circuits that drive normal physiological waking, while inhibiting sleep-promoting neurons in the ventrolateral preoptic nucleus through enhanced noradrenergic tone. It nudges multiple wake-promoting systems at once rather than slamming any one of them, which is probably why the subjective experience is closer to "not sleepy" than "stimulated."

Cognitive effects in healthy people. The 2015 Battleday and Brem systematic review of 24 studies in non-sleep-deprived adults found consistent benefits on attention, executive function, and learning, with the largest effects on the most complex and demanding tasks. Simple tasks (basic reaction time, easy arithmetic) showed minimal change. The pattern matches an older Cambridge trial in 60 young men where 100-200 mg improved digit span, visual pattern recognition, spatial planning, and stop-signal reaction time. In sleep-deprived people the effects are more obvious: 200-400 mg can keep people functional for 40+ hours on tasks that would otherwise fall apart.

The effect size in rested people is modest. A 2020 meta-analysis comparing modafinil, methylphenidate, and d-amphetamine in healthy non-sleep-deprived adults found small-to-moderate benefits across executive function and memory domains, with results varying by task. This is not a drug that turns an average person into a genius. It's a drug that makes a tired person perform like a rested one and helps a rested person sustain effort longer on hard tasks.

Tolerance and dependence. This is more contested than the labelling suggests. The 40-week narcolepsy extension trials found maintained efficacy with no consistent dose escalation, and the FDA classifies modafinil as Schedule IV (low abuse potential). But Volkow's 2009 PET imaging study found modafinil occupies dopamine transporters at levels comparable to therapeutic doses of methylphenidate and raises nucleus accumbens dopamine, which is the addiction-relevant signal. Real-world tolerance does develop in some long-term users, with case reports of escalation and a small number of dependence cases described. The clinical signal is: most people are fine using it intermittently, but daily use over months can erode the effect, and people with a personal or family history of stimulant addiction are at meaningfully higher risk than the average user.

Cardiovascular effects. Pooled clinical trial data in narcolepsy and OSA patients show modest mean increases in heart rate (around 1-3 bpm) and blood pressure (around 1-4 mmHg systolic), with no signal of major cardiac events. But a Vanderbilt crossover trial in 12 healthy subjects using a single 400 mg dose found resting heart rate up by 9 bpm, systolic BP up 7 mmHg, diastolic up 5 mmHg, and a 33% rise in urinary norepinephrine, suggesting clear sympathomedullary activation that the population averages mask. Practically: most people get a small bump that doesn't matter; some people get a bigger one. If you have hypertension, arrhythmia, or a structural heart issue, this is not a casual decision.

Women and contraception. Modafinil induces CYP3A4/5, which metabolises ethinyl estradiol. The Robertson 2002 trial gave 41 women on combined oral contraceptives 200-400 mg modafinil for 28 days and saw an 11% drop in EE2 Cmax and 18% drop in AUC. This is enough to compromise contraceptive efficacy, particularly with low-dose pills. The US and UK labels both require effective non-hormonal contraception during use and for 1-2 months after stopping. This applies equally to armodafinil. Modafinil's pharmacokinetics themselves don't differ meaningfully between sexes (per the FDA label) and the cognitive enhancement studies have included women throughout with comparable effects. The asymmetry is the contraceptive interaction, not the response to the drug.

Also important on the female side: modafinil and armodafinil are now flagged as possibly teratogenic. The US Provigil/Nuvigil Pregnancy Registry documented major congenital malformations in roughly 13% of live births with first-trimester exposure compared to ~3% in the general population, with cardiac defects, hypospadias, and orofacial clefts all overrepresented. A Danish registry study found a more modest signal, but the totality of evidence has driven contraindication during pregnancy in most jurisdictions. If there's any chance of pregnancy, this is a hard avoid.

Older adults. Oral clearance drops about 20% in older subjects. Use lower doses (50-100 mg modafinil or 50 mg armodafinil) and titrate. Cardiovascular monitoring matters more here.

Limitations of the evidence. Most cognitive trials are single-dose or short, run on young healthy men, and use lab tasks that don't always map to real-world performance. The largest effects are in sleep-deprived populations; the effects in rested people are real but smaller than the cultural reputation suggests. Long-term safety data beyond a year is thin. The dependence signal from imaging studies hasn't been matched by widespread clinical addiction, but absence of evidence at population scale doesn't rule it out at individual scale.

Dosage:

Modafinil standard dose: 100-200 mg in the morning, on waking. 200 mg is the FDA-approved adult dose for narcolepsy and OSA. Many users find 100 mg gives most of the benefit with fewer side effects, especially first-timers. 400 mg is the licensed maximum but doesn't reliably outperform 200 mg on most measures and increases side effect rates

Armodafinil standard dose: 150 mg in the morning. 250 mg is the upper licensed dose for shift work disorder. Roughly equivalent to 200 mg modafinil at peak but holds higher plasma levels into the evening, so think twice if you want to sleep that night

Timing: Take first thing on waking. Half-life is 12-15 hours for modafinil and 13-15 hours for armodafinil, so even a morning dose can disrupt sleep that night in sensitive people. Don't take after midday unless you're using it specifically for an overnight shift. Food doesn't change total absorption but slows onset by 30-60 minutes

Frequency: Use intermittently. Most users settle on 1-3 days a week max. Daily use erodes the subjective effect over weeks to months and increases tolerance risk. Build in days off

First time: Start at 50-100 mg of modafinil (split a 200 mg tablet) on a low-stakes day where you can afford to feel headachy or wired. Do not first-dose before something important. About 1 in 10 people get a strong headache or anxiety response that they'd rather not discover during a real test

Older adults: Reduce dose by half. 50-100 mg modafinil or 50 mg armodafinil. Clearance is slower and cardiovascular sensitivity is higher

Severe liver impairment: Halve the dose. Renal impairment doesn't require formal adjustment but caution is warranted at the higher end

Stacks: Pairs reasonably with caffeine, though many people find they don't need caffeine on a modafinil day. Pairs with L-theanine to soften any anxiety or jittery edge. Avoid stacking with other stimulants (amphetamines, high-dose pseudoephedrine) due to additive cardiovascular load. Don't drink heavily on it, the alcohol interaction is unpredictable and several users report blackout-level effects from modest drinking

Here's what you can expect:

You'll notice the effect 60-90 minutes after dosing. It's not a stimulant high. It's more that the urge to break focus, check your phone, or drift mentally just isn't there. You can sit with a hard task for hours. Time compresses. Many users describe it as forgetting to eat or stand up. Most also find their tolerance for boring or repetitive work improves more than their tolerance for creative work, where the rigidity of focus can sometimes hurt rather than help.

Appetite drops noticeably for most people. Plan to eat anyway, low blood sugar makes the side effects (headache, irritability) much worse. Hydrate aggressively. Many of the headaches people blame on modafinil are actually mild dehydration that the drug masks until it gets bad.

The come-down is usually unremarkable, you just notice you're tired, and that tiredness can hit later than expected because the half-life is long. Sleep that night is often shallower or shorter than usual. Plan recovery sleep for the next night, not the same night.

With repeated use over weeks to months, the subjective "on" feeling tends to fade while the underlying cognitive benefit may still be there but is harder to feel. This is one of the strongest arguments for keeping use intermittent.

Side effects & risks:

Headache is the most common side effect, reported by around 30% of users. Often dehydration-related and improves with water and food. Persistent severe headaches are a reason to lower the dose or stop

Insomnia is dose- and timing-dependent. Take it before 9-10 am, accept the night's sleep may be lighter. Armodafinil is more likely to interfere with sleep than modafinil

Anxiety, irritability, nervousness. More common at 200+ mg and in people prone to anxiety. If you notice your inner monologue getting harsh or your patience dropping, that's a dose signal, not a willpower issue

Appetite suppression. Real and consistent. Force meals on dosing days

Cardiovascular. Modest increases in heart rate and blood pressure on average, but individual responses can be larger. Avoid if you have uncontrolled hypertension, arrhythmia, recent MI, unstable angina, left ventricular hypertrophy, or mitral valve prolapse. Get a baseline BP and ideally an ECG if you have any cardiac history

Nausea, dry mouth, mild GI upset. Common, usually mild

Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS. Rare but serious skin reactions, mostly within the first six weeks of use. Any new rash, fever with rash, mouth or eye involvement, or peeling skin is a stop-and-seek-medical-attention signal. The absolute risk is low (single-digit cases per million prescriptions) but the consequences are severe

Psychiatric. Rare cases of psychosis, mania, and suicidal ideation, mostly in people with pre-existing psychiatric vulnerability. People with bipolar disorder or psychotic disorders should generally avoid it

Hormonal contraception. Modafinil and armodafinil reduce ethinyl estradiol levels enough to compromise efficacy. Use a non-hormonal method (copper IUD, condoms, sterilisation) or a hormonal IUD during use and for 2 months after stopping. This is not optional if pregnancy would be unwanted

Pregnancy. Avoid. The Provigil/Nuvigil Pregnancy Registry shows roughly 13% major congenital malformation rate vs ~3% baseline. Confirm not pregnant before use if relevant

Drug interactions. Modafinil induces CYP3A4 (lowers levels of statins, ciclosporin, hormonal contraceptives, some antivirals) and inhibits CYP2C19 (raises levels of phenytoin, diazepam, omeprazole, propranolol, clomipramine, some SSRIs). Warfarin/INR monitoring should be tightened if both are used. Avoid combining with MAOIs

Tolerance and dependence. Lower than amphetamines but real. Daily use over months can produce reduced effect and a withdrawal-like fatigue and low mood when stopping. People with a history of stimulant misuse should treat this drug with the same caution as any other dopaminergic stimulant

Legal status. Schedule IV in the US, prescription-only in the UK, EU, Australia, and most jurisdictions. Possession without a prescription is illegal in most countries. Online supply is a real risk for counterfeit product

🩸

Blood markers

Blood pressure and resting heart rate, baseline before starting and rechecked after a few weeks of use. The population average increase is small but individual responses vary, and you want to catch a personal outlier before it matters. Anyone with a cardiac history should also get a baseline ECG.

Liver enzymes (ALT, AST, GGT), baseline if you plan to use it more than occasionally. Modafinil is hepatically metabolised and rare hepatic adverse events have been reported. Recheck at 6-12 months of regular use.

Pregnancy test (hCG) before starting in any woman of reproductive age, even if contraception is in place. The teratogenicity signal is strong enough that confirming non-pregnant status before first dose is the responsible move.

INR if you're on warfarin, before and after starting, with closer monitoring for the first month.

For occasional users (a few times a month) with no cardiac, hepatic, or psychiatric history and no relevant co-medications, baseline BP and a one-time pregnancy check (where relevant) are usually enough. Anyone using daily, anyone with relevant health history, and anyone stacking with other compounds should run the fuller panel.

Modafinil and armodafinil are prescription medicines in most countries. Quality and identity of online supply is unreliable.